Lucid Diagnostics, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2018-05-30
- Employees
- 70
- Market Cap
- -
- Website
- http://www.luciddx.com
CLUE: CLinical Utility Study of EsoGuard
Not Applicable
Recruiting
- Conditions
- Esophagus AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
- Interventions
- Device: EsoGuard
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT06030180
- Locations
- ๐บ๐ธ
Texas Digestive Specialists, Harlingen, Texas, United States
๐บ๐ธColorado Primary Healthcare, Littleton, Colorado, United States
๐บ๐ธArkansas Heartburn Treatment Center, Heber Springs, Arkansas, United States
Lucid Registry Study
Recruiting
- Conditions
- Barretts Esophagus With DysplasiaBarrett's Esophagus Without DysplasiaBarrett EsophagusEsophageal Adenocarcinoma
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05965999
- Locations
- ๐บ๐ธ
LUCID DX, Lake Forest, California, United States
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
Not Applicable
Completed
- Conditions
- Barrett Esophagus
- Interventions
- Device: EsoGuard result
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT05778851
- Locations
- ๐บ๐ธ
Lucid Diagnostics, New York, New York, United States
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
Not Applicable
Recruiting
- Conditions
- Barrett EsophagusBarretts Esophagus With DysplasiaEsophageal AdenocarcinomaBarrett's Esophagus Without Dysplasia
- Interventions
- Device: EsoGuard (lab assay)Diagnostic Test: Esophagogastroduodenoscopy
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 470
- Registration Number
- NCT04295811
- Locations
- ๐ณ๐ฑ
Lucid Investigative Site, Rotterdam, Netherlands
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
Not Applicable
Completed
- Conditions
- Barrett EsophagusBarretts Esophagus With DysplasiaBarrett's Esophagus Without DysplasiaEsophageal Adenocarcinoma
- Interventions
- Device: EsoGuard
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT04293458
- Locations
- ๐ช๐ธ
Lucid Investigative Site, Zaragoza, Spain
ยฉ Copyright 2025. All Rights Reserved by MedPath